CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,645,572 | +36.2% | 1,787,094 | 0.0% | 14.80% | +53.8% |
| Q2 2023 | $19,568,679 | +25.6% | 1,787,094 | 0.0% | 9.62% | +19.0% |
| Q1 2023 | $15,583,460 | +39.1% | 1,787,094 | 0.0% | 8.09% | +69.0% |
| Q4 2022 | $11,205,079 | +79.1% | 1,787,094 | 0.0% | 4.79% | +137.9% |
| Q3 2022 | $6,255,000 | +18.6% | 1,787,094 | 0.0% | 2.01% | +41.7% |
| Q2 2022 | $5,272,000 | -5.1% | 1,787,094 | 0.0% | 1.42% | -8.7% |
| Q1 2022 | $5,558,000 | -8.0% | 1,787,094 | 0.0% | 1.56% | +25.1% |
| Q4 2021 | $6,040,000 | -7.4% | 1,787,094 | 0.0% | 1.24% | +29.3% |
| Q3 2021 | $6,523,000 | -16.3% | 1,787,094 | 0.0% | 0.96% | -8.7% |
| Q2 2021 | $7,792,000 | -4.0% | 1,787,094 | 0.0% | 1.05% | +8.3% |
| Q1 2021 | $8,113,000 | -20.9% | 1,787,094 | 0.0% | 0.97% | -12.7% |
| Q4 2020 | $10,258,000 | -20.7% | 1,787,094 | 0.0% | 1.11% | -61.8% |
| Q3 2020 | $12,939,000 | +30.4% | 1,787,094 | -37.2% | 2.92% | -39.6% |
| Q2 2020 | $9,925,000 | +118.8% | 2,843,893 | +22.8% | 4.84% | +146.9% |
| Q4 2019 | $4,537,000 | -57.0% | 2,315,016 | +12.4% | 1.96% | -42.6% |
| Q3 2019 | $10,549,000 | -42.7% | 2,060,268 | -19.9% | 3.41% | -34.5% |
| Q2 2019 | $18,410,000 | -47.3% | 2,571,258 | -2.3% | 5.20% | -58.6% |
| Q1 2019 | $34,943,000 | +68.7% | 2,631,258 | 0.0% | 12.56% | +32.1% |
| Q4 2018 | $20,708,000 | -7.6% | 2,631,258 | +30.0% | 9.50% | +29.3% |
| Q3 2018 | $22,419,000 | -17.4% | 2,023,369 | 0.0% | 7.35% | -20.6% |
| Q2 2018 | $27,154,000 | -1.0% | 2,023,369 | -4.2% | 9.26% | -18.6% |
| Q1 2018 | $27,433,000 | +32.3% | 2,111,869 | -6.3% | 11.37% | -21.8% |
| Q4 2017 | $20,741,000 | – | 2,254,502 | – | 14.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,629,464 | $14,208,926 | 10.61% |
| Lynx1 Capital Management LP | 1,369,927 | $11,945,763 | 9.96% |
| Versant Venture Management, LLC | 543,753 | $4,741,526 | 9.88% |
| Foresite Capital Management IV, LLC | 1,787,094 | $15,583,460 | 8.09% |
| Octagon Capital Advisors LP | 4,570,918 | $39,858,405 | 5.74% |
| ACUTA CAPITAL PARTNERS, LLC | 878,500 | $7,660,520 | 5.64% |
| TCG Crossover Management, LLC | 3,048,257 | $26,580,801 | 5.18% |
| Affinity Asset Advisors, LLC | 1,083,118 | $9,444,789 | 3.12% |
| Altium Capital Management LP | 620,000 | $5,406,400 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 2,500,000 | $21,800 | 2.72% |